Irinotecan plus S-1 for liver metastases of gastric cancer

Hepato-Gastroenterology

Volumn 56, Issue 96, 2009, Pages 1755-1759

  Kochi, Mitsugu ^a   Fujii, Masashi ^a   Kanamori, Noriaki ^a   Kaiga, Teruo ^a   Okubo, Riki ^a   Hagiwara, Ken ^a   Funada, Tomoya ^a   Tamegai, Hidenori ^a   Takayama, Tadatoshi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer; Chemotherapy; CPT 11 and S 1; Gastric; Liver; Metastasis; Prognosis

Indexed keywords

CISPLATIN; DOCETAXEL; IRINOTECAN; NUCLEASE S1;

ADULT; AGED; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG RESPONSE; FEMALE; HAND FOOT SYNDROME; HAZARD RATIO; HUMAN; HUMAN TISSUE; LEUKOPENIA; LIVER DYSFUNCTION; LIVER METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; SKIN MANIFESTATION; STOMACH CANCER; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; DRUG COMBINATIONS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OXONIC ACID; STOMACH NEOPLASMS; TEGAFUR;

EID: 74949096626     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sakamoto J, Nakazato H, Teramukai S, Ohashi Y, Takahashi Y, Mai M, Toge T, Okura H, Kodaira S, Maetani S, Okajima K, Nomoto K, Hattori T, Inokuchi K: Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan. Surg Oncol 1996; 5:133-139
2. Roh HR, Suh KS, Lee HJ, Yang HK, Choe KJ, Lee KU: Outcome of hepatic resection for metastatic gastric cancer. Am Surg 2005;71:95-99.
3. Ohkuwa M, Ohtsu A, Boku N, Yoshida S, Miyata Y, Shirao K, Shimada Y, Kurihara M: Long-term results for patients with unresectable gastric cancer who received chemotherapy in the Japan Clinical Oncology Group (JCOG) trials. Gastric cancer 2000;3:145-150.
4. Zacherl J, Zacherl M, Scheuba C, Steininger R, Wenzl E, Mühlbacher F, Jakesz R, Längle F: Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 2002;6:682-689.
5. Sugimachi K, Maehara Y, Horikoshi N, Shimada Y, Sakata Y, Mitachi Y, Taguchi T: An early phase study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers: The S-1 Gastrointestinal Cancer Study Group. Oncology 1999;57:202-210
6. Sakata Y, Ohtsu A, Horikoshi N, Sugimachi K, Mitachi Y, Taguchi T: Late phase II study of novel oral fiuoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients. Eur J Cancer 1998; 34:1715-1720.
7. Kawano Y, Aonuma M, Hirota Y, Kuga H, Sato K: Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 1991;51:4187-4191
8. Research group of CPT-11 in Gynecologic Cancers: An early phase II trial of CPT-11 in patients with advanced gastrointestinal cancer. J Jpn Soc Cancer Ther 1992;27:2028-2035
9. Takiuchi H, Narahara H, Tsujinaka T, Gotoh M, Kawabe S, Katsu K, Iishi H, Tatsuta M, Fujitani K, Furukawa H, Taguchi T: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG): Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002). Jpn J Clin Oncol. 2005;35:520-525.
10. Yamada Y, Yasui H, Goto A, Arai T, Ura T, Hamaguchi T, Muro K, Shimada Y, Shirao K: Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer. Int J Clin Oncol 2003;8:374-380
11. Inokuchi M, Yamashita T, Yamada H, Kojima K, Ichikawa W, Nihei Z, Kawano T, Sugihara K: Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer. Br J Cancer 2006;94:1130-1135
12. Katsube T, Ogawa K, Ichikawa W, Fujii M, Tokunaga A, Takagi Y, Kocji M, Hayashi K, Kubota T, Aiba K, Arai K, Terashima M, Kitajima M: Phase I/II study of irinotecan (CPT-11) and S-1 in the treatment of advanced gastric cancer. Anti-cancer Drugs 2007;18:605-610
13. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer inst 2000;92:205-216.
14. Degiuli M, Sasako M, Ponti A, Calvo F: Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer. 2004; 4:1727-32.
15. Edwards P, Blackshaw GR, Lewis WG, Barry JD, Allison MC, Jones DR: Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer.2004;17:1888-1892.
16. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, Meyer S, Plukker JT, Van Elk P, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H: Dutch Gastric Cancer Group: Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;25:908-914.
17. Ajani JA, Faust J, Ikeda K, Yao JC, Anbe H, Carr KL, Houghton M, Urrea P: Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma. J Clin Oncol 2005;1:6957-6965.
18. Koizumi W, Tanabe S, Saigenji K, Ohtsu A, Boku N, Nagashima F, Shirao K, Matsumura Y, Gotoh M: Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer 2003;15:2207-2212.
19. Kochi M, Fujii M, Kanamori N, Kaiga T, Takahashi T, Kobayashi M, Takayama T: Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer. Cancer Res CUn Oncol. 2006 ;132:781-785.
20. Nakajima T, Nashimoto A, Kitamura M, Kito T, Iwanaga T, Okabayashi K, Goto M: Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group. Lancet 1999;24:273-277.
21. Kochi M, Fujii M, Kaiga T Takahashi T, Morishita Y, Kobayashi M, Kasakura Y, Takayama T: FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer. Oncology 2004;66:445-449
22. Ihling C, Schaefer HE, Baumgartner U, Riede UN: Hepatoid adenocarcinoma of the stomach: a case report. Gen Diagn Pathol 1995;141:61-65.